HealthMyne has signed a joint development agreement with Mayo Clinic to evaluate the Quantitative Imaging Decision Support (QIDS)® platform in their Scottsdale, AZ facility for Therapy Response Assessments, which allows for a standardized method of determining the effectiveness of various treatment protocols used in cancer care. In current practice, due to significant inefficiencies in the process, these assessments are generally limited to patients involved in clinical trials.
HealthMyne’s QIDS platform enables better patient management decisions for hospital providers worldwide by connecting the Point-of-Read (Radiology) with the Point-of-Care starting with Oncology and expanding to other specialties over time. The QIDS platform drives collaboration by providing the multidisciplinary care team with intuitive, workflow-integrated software that leverages imaging and clinical data to enhance the quality and cost of care. The Clinical Decision Support (CDS) modules in the platform–Cancer Screening, Tumor Conferences, Therapy Response, Incidental Findings, Thoracic, others–significantly automate and streamline inefficient and cost-intensive clinical processes to allow busy clinicians to focus their energies on precise patient management.
Read more at EINNews.com.